• Multiple Myeloma 

Dr. Hartley-Brown is an emerging national leader in the field of Multiple Myeloma. She is an attending Medical Oncologist who specializes in treating patients with multiple myeloma. She practices clinical care at the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. Multiple myeloma is an incurable cancer that affects Black Americans approximately twice more than Caucasians. Dr. Hartley-Brown has written several publications and has been a clinical research investigator for numerous clinical studies that have contributed to the advancement of clinical care for patients with multiple myeloma and plasma cell dyscrasias. As a Black female physician, she is dedicated to ensuring that the care for the myeloma community is equitable and affords all patients with myeloma an optimal level of care regardless of background, race or socioeconomic status.

Some of her accolades include being a prior recipient of the John W.V. Cordice, Sr., Honors award in 2004 from New York University School of Medicine, recipient of the K30 Scholarship award for research and career development in 2008 from the University of South Florida, and recipient of the Fellow Scholarship award in 2010 from American Society of Oncology (ASCO). She remains actively involved within the American Society of Hematology (ASH) as an ambassador, mentor and grant reviewer. She is also very active within the Alliance for clinical trials, as a member of the Multiple Myeloma committee, dedicated to working within the consortium to advance clinical trials and novel therapies for advancing treating outcomes for patients with multiple myeloma.